Debevoise Advises the Special Committee of R1 RCM in Its Conversion Agreement with Ascension and TowerBrook

8 January 2021

Debevoise & Plimpton LLP is advising the special committee of R1 RCM Inc. (NASDAQ: RCM) in its conversion of all of the Series A Convertible Preferred Stock held by an investment vehicle jointly owned by Ascension Health Alliance (“Ascension”) and investment funds affiliated with TowerBrook Capital Partners L.P. (“TowerBrook”) to common stock. For more information, please see the company’s press release.

R1 RCM is a leading provider of technology-enabled revenue cycle management (RCM) services which transform and solve revenue cycle performance challenges across hospitals, health systems and group physician practices. Ascension is a faith-based, non-profit healthcare organization dedicated to transformation through innovation across the continuum of care. TowerBrook is an international investment management firm.

The Debevoise team is led by M&A partners William Regner and Jeffrey Rosen and includes associates Erik Andren and Marisa Demko, capital markets partner Steven Slutzky and litigation partner Maeve O'Connor.